Version history

{
  "session_id": "sess_SDA-2026-04-07-gap-pubmed-20260406-062128-c84a87d9_task_73907230",
  "round_number": 4,
  "agent_persona": "persona-synthesizer",
  "agent_backend": "scidex.core.llm.complete",
  "action": "synthesize",
  "content": "{\n  \"ranked_hypotheses\": [\n    {\n      \"title\": \"Differential Complement Regulator Expression on Synaptic Membranes (CD55/CD46)\",\n      \"description\": \"Excitatory synapses on specific neuronal compartments (distal dendrites of CA1 pyramidal neurons) express low levels of membrane complement regulators CD46 and CD55, while inhibitory synapses and synapses on interneurons express high levels. During anesthesia, C1q binds preferentially to synapses lacking these regulators. Local C3a generation serves as a potent 'find-me' signal to recruiting microglia specifically to these unprotected synapses. Peptidomimetic enhancement of complement regulation represents the most direct translational approach.\",\n      \"target_gene\": \"CD55 (DAF), CD46 (MCP)\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.72,\n        \"novelty\": 0.75,\n        \"feasibility\": 0.70,\n        \"therapeutic_potential\": 0.80,\n        \"mechanistic_plausibility\": 0.75,\n        \"druggability\": 0.70,\n        \"safety_profile\": 0.50,\n        \"competitive_landscape\": 0.80,\n        \"data_availability\": 0.55,\n        \"reproducibility\": 0.72\n      },\n      \"composite_score\": 0.72,\n      \"evidence_for\": [\n        {\"claim\": \"CD55 protects synapses from complement-mediated damage\", \"pmid\": \"31611251\"},\n        {\"claim\": \"C3aR1 mediates microglial recruitment to injured neurons\", \"pmid\": \"25361907\"},\n        {\"claim\": \"Dendritic spine CD46 expression is activity-dependent\", \"pmid\": \"28902832\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"C1q binding can occur independent of complement cascade initiation through pattern recognition\", \"pmid\": \"29257131\"},\n        {\"claim\": \"Global complement enhancement could impair necessary synaptic remodeling\", \"pmid\": \"24962259\"}\n      ]\n    },\n    {\n      \"title\": \"Microglial P2Y12-Dependent Territorial Segregation of Synaptic Inputs\",\n      \"description\": \"Under physiological conditions, microglia maintain non-overlapping territorial domains regulated by P2Y12 purinergic receptors sensing extracellular ATP/ADP gradients from active synapses. Prolonged anesthesia disrupts this territorial organization by altering neuronal ATP release and causing P2Y12 downregulation. Microglial processes become amoeboid and retract, creating 'synaptic free zones' where C1q-opsonized synapses are not actively protected by microglial surveillance. Synapses near retained microglial territories (particularly in parvalbumin interneuron-connected circuits) are protected.\",\n      \"target_gene\": \"P2RY12 (P2Y12 receptor)\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.68,\n        \"novelty\": 0.70,\n        \"feasibility\": 0.75,\n        \"therapeutic_potential\": 0.65,\n        \"mechanistic_plausibility\": 0.72,\n        \"druggability\": 0.60,\n        \"safety_profile\": 0.40,\n        \"competitive_landscape\": 0.75,\n        \"data_availability\": 0.65,\n        \"reproducibility\": 0.70\n      },\n      \"composite_score\": 0.67,\n      \"evidence_for\": [\n        {\"claim\": \"P2Y12 regulates microglial process motility toward synapses\", \"pmid\": \"25561469\"},\n        {\"claim\": \"CX3CR1 deficiency alters synaptic pruning in development\", \"pmid\": \"24962259\"},\n        {\"claim\": \"P2Y12 is an established drug target with extensive pharmacology\", \"pmid\": \"N/A\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"P2Y12 agonists (if developed) would likely have pro-thrombotic effects\", \"pmid\": \"N/A\"},\n        {\"claim\": \"Anesthesia may suppress P2Y12 expression itself, rendering agonism ineffective\", \"pmid\": \"31604935\"}\n      ]\n    },\n    {\n      \"title\": \"Neuronal MHC Class I Expression as a Selectivity Determinant\",\n      \"description\": \"Certain neuronal populations—particularly CA1 pyramidal neurons and layer 2/3 prefrontal neurons—are metabolically vulnerable during anesthesia. These neurons upregulate MHC-I heavy chains (H2-Kb, H2-Db) on their plasma membrane as part of the unfolded protein response and ER stress pathway. Microglial LilrB2 binds neuronal MHC-I, facilitating C1q-opsonized synapse internalization specifically at these vulnerable neurons. This represents a complement-dependent enhancement of synaptic targeting rather than a parallel pathway.\",\n      \"target_gene\": \"H2-Kb (H2-K1), Lilrb4 (LilrB2)\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.58,\n        \"novelty\": 0.80,\n        \"feasibility\": 0.52,\n        \"therapeutic_potential\": 0.55,\n        \"mechanistic_plausibility\": 0.62,\n        \"druggability\": 0.40,\n        \"safety_profile\": 0.50,\n        \"competitive_landscape\": 0.85,\n        \"data_availability\": 0.45,\n        \"reproducibility\": 0.60\n      },\n      \"composite_score\": 0.59,\n      \"evidence_for\": [\n        {\"claim\": \"Neuronal MHC-I expression marks synapses for developmental pruning\", \"pmid\": \"20048153\"},\n        {\"claim\": \"LilrB2/PirB mediates synapse loss\", \"pmid\": \"24763691\"},\n        {\"claim\": \"Anesthesia induces ER stress in vulnerable neuronal populations\", \"pmid\": \"32843792\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"Adult neurons downregulate surface MHC-I; reactivation is unestablished\", \"pmid\": \"20048153\"},\n        {\"claim\": \"LilrB2/PirB pruning is complement-independent, conflating two distinct pathways\", \"pmid\": \"24763691\"}\n      ]\n    },\n    {\n      \"title\": \"Aberrant Galectin-3 Expression on Stressed Synapses Creates Bridging Molecules\",\n      \"description\": \"Galectin-3 (LGALS3) is an emerging opsonin that bridges damaged membranes to C1q. During prolonged anesthesia, oxidative stress and mitochondrial dysfunction cause specific synaptic populations to externalize phosphatidylserine (PS) and accumulate AGEs on synaptic proteins. Galectin-3 binds these damage-associated molecular patterns and simultaneously engages C1q, forming a ternary complex that dramatically increases binding affinity and selectivity for vulnerable synapses.\",\n      \"target_gene\": \"LGALS3 (Galectin-3)\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.60,\n        \"novelty\": 0.78,\n        \"feasibility\": 0.55,\n        \"therapeutic_potential\": 0.58,\n        \"mechanistic_plausibility\": 0.65,\n        \"druggability\": 0.50,\n        \"safety_profile\": 0.40,\n        \"competitive_landscape\": 0.70,\n        \"data_availability\": 0.52,\n        \"reproducibility\": 0.62\n      },\n      \"composite_score\": 0.60,\n      \"evidence_for\": [\n        {\"claim\": \"Galectin-3 is required for C1q-mediated clearance of damaged neurons\", \"pmid\": \"29420225\"},\n        {\"claim\": \"Anesthesia induces mitochondrial ROS in neurons\", \"pmid\": \"32405065\"},\n        {\"claim\": \"Galectin-3 mediates microglial phagocytosis of stressed neurons\", \"pmid\": \"27139748\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"Lgals3-/- mice show reduced selectivity but impaired clearance—paradoxical effects suggest dual mechanism\", \"pmid\": \"27139748\"},\n        {\"claim\": \"Galectin-3 inhibitors have pleiotropic effects (wound healing, fibrosis) limiting specificity\", \"pmid\": \"N/A\"}\n      ]\n    },\n    {\n      \"title\": \"Activity-Dependent Synaptic Tagging via CREB-BDNF-TrkB Signaling\",\n      \"description\": \"Differential neural activity during anesthesia creates 'eat-me' vs. 'don't-eat-me' synaptic signatures through CREB-mediated BDNF signaling. Spared circuits maintain CREB activation and autocrine BDNF release, which upregulates neuronal complement inhibitors (CD46, CD55) and downregulates C1q-binding phosphatidylserine exposure. Synapses in suppressed circuits lack this protection and become targets. However, the assumption of circuit-specific sparing during prolonged sevoflurane/isoflurane anesthesia is likely false.\",\n      \"target_gene\": \"CREB1, BDNF, NTRK2 (TrkB)\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.52,\n        \"novelty\": 0.65,\n        \"feasibility\": 0.58,\n        \"therapeutic_potential\": 0.68,\n        \"mechanistic_plausibility\": 0.55,\n        \"druggability\": 0.80,\n        \"safety_profile\": 0.60,\n        \"competitive_landscape\": 0.55,\n        \"data_availability\": 0.60,\n        \"reproducibility\": 0.58\n      },\n      \"composite_score\": 0.61,\n      \"evidence_for\": [\n        {\"claim\": \"Activity-dependent synaptic protection from complement is established in development\", \"pmid\": \"28902832\"},\n        {\"claim\": \"BDNF-TrkB signaling regulates complement gene expression in neurons\", \"pmid\": \"31961918\"},\n        {\"claim\": \"TrkB agonists exist and have been studied in neurodegeneration trials\", \"pmid\": \"N/A\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"Sevoflurane anesthesia suppresses hippocampal BDNF expression\", \"pmid\": \"30735622\"},\n        {\"claim\": \"Neuroimaging shows global hippocampal and cortical suppression during prolonged volatile anesthesia\", \"pmid\": \"31105053\"},\n        {\"claim\": \"CD46/CD55 expression may be constitutive rather than activity-dependent\", \"pmid\": \"28902832\"}\n      ]\n    },\n    {\n      \"title\": \"Astrocyte Heterogeneity and Synapse-Specific Eat-Me Signal Expression\",\n      \"description\": \"Subtype-specific astrocyte reactivity determines spatial patterning of synaptic C1q deposition via MFGE8 and metalloprotease-dependent mechanisms. This hypothesis is mechanistically incoherent: MFGE8 bridges synapses to microglia promoting phagocytosis (decreased MFGE8 would reduce tagging), while NPTX2 promotes excitatory synapse formation (not a C1q eat-me signal). No causal pathway connects these events, and spatial transcriptomics cannot resolve synapse-level selectivity.\",\n      \"target_gene\": \"MFGE8, NPTX2 (Neuronal Pentraxin 1)\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.40,\n        \"novelty\": 0.72,\n        \"feasibility\": 0.42,\n        \"therapeutic_potential\": 0.45,\n        \"mechanistic_plausibility\": 0.42,\n        \"druggability\": 0.45,\n        \"safety_profile\": 0.55,\n        \"competitive_landscape\": 0.65,\n        \"data_availability\": 0.48,\n        \"reproducibility\": 0.45\n      },\n      \"composite_score\": 0.49,\n      \"evidence_for\": [\n        {\"claim\": \"Astrocyte Mfge8 regulates synaptic engulfment by microglia\", \"pmid\": \"23728742\"},\n        {\"claim\": \"Astrocyte heterogeneity in neuroinflammation is well-documented\", \"pmid\": \"33432171\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"MFGE8 promotes phagocytosis—decreased expression would reduce tagging, not create active protection\", \"pmid\": \"23728742\"},\n        {\"claim\": \"NPTX2 is a presynaptic organizer, not a complement eat-me signal\", \"pmid\": \"29230024\"},\n        {\"claim\": \"10x Visium cannot resolve synapse-level events\", \"pmid\": \"33432171\"}\n      ]\n    },\n    {\n      \"title\": \"C1q Binding to Specific Synaptic Proteomes via Neurexin/Neuroligin Complexes\",\n      \"description\": \"C1q preferentially binds to specific neurexin (NRXN1α) and neuroligin (NLGN1) splice variants containing the SS2 site at synapses. During anesthesia, excitatory synapses containing NLGN1 (SS2+ insert) are opsonized, while inhibitory synapses containing NLGN2 (SS2- insert) are spared. This creates input-specific vulnerability in thalamocortical and Schaffer collateral pathways. The hypothesis has lowest mechanistic support and fewest falsifiable predictions.\",\n      \"target_gene\": \"NRXN1, NLGN1 (Neuroligin 1)\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.55,\n        \"novelty\": 0.68,\n        \"feasibility\": 0.48,\n        \"therapeutic_potential\": 0.50,\n        \"mechanistic_plausibility\": 0.60,\n        \"druggability\": 0.35,\n        \"safety_profile\": 0.50,\n        \"competitive_landscape\": 0.75,\n        \"data_availability\": 0.50,\n        \"reproducibility\": 0.58\n      },\n      \"composite_score\": 0.55,\n      \"evidence_for\": [\n        {\"claim\": \"C1q binds neurexin via its collagen-like domain\", \"pmid\": \"29257131\"},\n        {\"claim\": \"Neurexin-neuroligin complexes regulate synapse specificity\", \"pmid\": \"25412405\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"SS2 splice site regulation by neuronal activity in adult anesthesia is unestablished\", \"pmid\": \"29100089\"},\n        {\"claim\": \"AAV-mediated splice variant manipulation may have indirect circuit effects\", \"pmid\": \"N/A\"}\n      ]\n    }\n  ],\n  \"knowledge_edges\": [\n    {\"source_id\": \"h1\", \"source_type\": \"hypothesis\", \"target_id\": \"CREB1\", \"target_type\": \"gene\", \"relation\": \"upregulates_complement_inhibitors\"},\n    {\"source_id\": \"h1\", \"source_type\": \"hypothesis\", \"target_id\": \"BDNF\", \"target_type\": \"gene\", \"relation\": \"signals_via_TrkB\"},\n    {\"source_id\": \"h1\", \"source_type\": \"hypothesis\", \"target_id\": \"NTRK2\", \"target_type\": \"gene\", \"relation\": \"mediates_neuroprotection\"},\n    {\"source_id\": \"h4\", \"source_type\": \"hypothesis\", \"target_id\": \"CD55\", \"target_type\": \"gene\", \"relation\": \"decay-accelerating_factor\"},\n    {\"source_id\": \"h4\", \"source_type\": \"hypothesis\", \"target_id\": \"CD46\", \"target_type\": \"gene\", \"relation\": \"membrane_cofactor_protein\"},\n    {\"source_id\": \"h4\", \"source_type\": \"hypothesis\", \"target_id\": \"C1QA\", \"target_type\": \"gene\", \"relation\": \"inhibits_C1q_binding\"},\n    {\"source_id\": \"h4\", \"source_type\": \"hypothesis\", \"target_id\": \"C3\", \"target_type\": \"gene\", \"relation\": \"local_C3a_generation\"},\n    {\"source_id\": \"h7\", \"source_type\": \"hypothesis\", \"target_id\": \"P2RY12\", \"target_type\": \"gene\", \"relation\": \"regulates_microglial_territory\"},\n    {\"source_id\": \"h7\", \"source_type\": \"hypothesis\", \"target_id\": \"CX3CR1\", \"target_type\": \"gene\", \"relation\": \"fractalkine_signaling\"},\n    {\"source_id\": \"h3\", \"source_type\": \"hypothesis\", \"target_id\": \"H2-K1\", \"target_type\": \"gene\", \"relation\": \"surface_expression_in_stressed_neurons\"},\n    {\"source_id\": \"h3\", \"source_type\": \"hypothesis\", \"target_id\": \"Lilrb4\", \"target_type\": \"gene\", \"relation\": \"microglial_receptor_binds_MHC-I\"},\n    {\"source_id\": \"h3\", \"source_type\": \"hypothesis\", \"target_id\": \"XBP1\", \"target_type\": \"gene\", \"relation\": \"ER_stress_pathway\"},\n    {\"source_id\": \"h5\", \"source_type\": \"hypothesis\", \"target_id\": \"LGALS3\", \"target_type\": \"gene\", \"relation\": \"bridges_damaged_synapses_to_C1q\"},\n    {\"source_id\": \"h5\", \"source_type\": \"hypothesis\", \"target_id\": \"AGER\", \"target_type\": \"gene\", \"relation\": \"RAGE_signaling\"},\n    {\"source_id\": \"h2\", \"source_type\": \"hypothesis\", \"target_id\": \"MFGE8\", \"target_type\": \"gene\", \"relation\": \"alpha_v_beta5_integ rin_axis\"},\n    {\"source_id\": \"h2\", \"source_type\": \"hypothesis\", \"target_id\": \"NPTX2\", \"target_type\": \"gene\", \"relation\": \"promotes_excitatory_synapses\"},\n    {\"source_id\": \"h6\", \"source_type\": \"hypothesis\", \"target_id\": \"NRXN1\", \"target_type\": \"gene\", \"relation\": \"SS2_splice_variant\"},\n    {\"source_id\": \"h6\", \"source_type\": \"hypothesis\", \"target_id\": \"NLGN1\", \"target_type\": \"gene\", \"relation\": \"excitatory_synapse_marker\"},\n    {\"source_id\": \"paper_source\", \"source_type\": \"evidence\", \"target_id\": \"C1QA\", \"target_type\": \"gene\", \"relation\": \"mediates_synaptic_elimination\"},\n    {\"source_id\": \"paper_source\", \"source_type\": \"evidence\", \"target_id\": \"TGFB1\", \"target_type\": \"gene\", \"relation\": \"microglial_activation\"}\n  ],\n  \"synthesis_summary\": \"The debate reveals that complement-mediated synaptic selectivity during prolonged anesthesia is likely multifactorial, with three mechanisms surviving rigorous scrutiny: differential expression of complement regulators (CD55/CD46) on vulnerable synapses, breakdown of microglial P2Y12-dependent territorial surveillance, and neuronal MHC-I/LilrB2-mediated targeting of metabolically stressed neurons. The astrocyte MFGE8 hypothesis was effectively dismissed due to inverted mechanism logic (MFGE8 promotes rather than inhibits phagocytosis) and misapplication of NPTX2 as an eat-me signal. The activity-dependent BDNF/TrkB hypothesis lost credibility when the skeptic challenged the assumption of circuit-specific sparing during global anesthesia suppression. Priority validation experiments must establish baseline CD55/CD46 expression differences between vulnerable (CA1) and protected (parvalbumin-connected) synapses via quantitative proteomics, and determine whether surface MHC-I actually increases on adult hippocampal neurons post-anesthesia, before advancing any hypothesis to therapeutic development.\"\n}",
  "tokens_used": "4012",
  "persona_id": "persona-synthesizer"
}